This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

McKesson Europe Past Earnings Performance

Past criteria checks 0/6

McKesson Europe's earnings have been declining at an average annual rate of -2039.3%, while the Healthcare industry saw earnings growing at 3.8% annually. Revenues have been growing at an average rate of 8.7% per year.

Key information

-2,039.3%

Earnings growth rate

-2,039.3%

EPS growth rate

Healthcare Industry Growth	15.7%
Revenue growth rate	8.7%
Return on equity	-2.0%
Net Margin	-0.6%
Last Earnings Update	31 Mar 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How McKesson Europe makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

HMSE:CLS1 Revenue, expenses and earnings (EUR Millions)
Date	Revenue	Earnings	G+A Expenses
31 Mar 22	9,257	-54	450
31 Mar 21	8,518	3	484
31 Mar 20	17,118	-71	1,146
31 Mar 19	16,417	-47	1,159
31 Mar 18	21,090	-303	1,416
31 Mar 17	20,644	-807	1,260
31 Dec 16	20,475	-76	2,333
30 Sep 16	21,118	437	1,354
30 Jun 16	21,265	459	1,387
31 Mar 16	21,193	487	1,428
31 Mar 15	21,076	129	1,352
31 Dec 14	20,647	187	1,347
30 Sep 14	21,877	79	1,454
30 Jun 14	21,606	64	1,443
31 Mar 14	21,426	167	1,422
31 Dec 13	21,408	165	1,419
30 Sep 13	21,565	146	1,392
30 Jun 13	21,753	153	1,389
31 Mar 13	21,990	99	1,418
31 Dec 12	22,271	103	1,428
30 Sep 12	22,339	51	1,447
30 Jun 12	22,347	72	1,440

Quality Earnings: CLS1 is currently unprofitable.

Growing Profit Margin: CLS1 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if CLS1's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare CLS1's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CLS1 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-23.9%).

Return on Equity

High ROE: CLS1 has a negative Return on Equity (-1.96%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/06/27 13:50
End of Day Share Price	2023/06/14 00:00
Earnings	2022/03/31
Annual Earnings	2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

McKesson Europe AG is covered by 28 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Eileen Ryan	AlphaValue
Alexandra Roche	Berenberg
Andreas Inderst	BNP Paribas Exane